"10.1371_journal.pone.0055174","plos one","2013-02-28T00:00:00Z","Vicky Wang-Wei Tsai; Laurence Macia; Heiko Johnen; Tamara Kuffner; Rakesh Manadhar; Sebastian Beck Jørgensen; Ka Ki Michelle Lee-Ng; Hong Ping Zhang; Liyun Wu; Christopher Peter Marquis; Lele Jiang; Yasmin Husaini; Shu Lin; Herbert Herzog; David A Brown; Amanda Sainsbury; Samuel N Breit","St Vincent’s Centre for Applied Medical Research, St Vincent’s Hospital and University of New South Wales, Sydney, New South Wales, Australia; Neuroscience Program, Garvan Institute of Medical Research, Sydney, New South Wales, Australia; Diabetes Research Unit, Novo Nordisk A/S, Maaloev, Denmark; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, New South Wales, Australia","Conceived and designed the experiments: VWT LM HJ TK SBJ SL HH DAB AS SNB. Performed the experiments: VWT LM HJ TK RM KKML HZ LW CPM LJ YH. Analyzed the data: VWT LM HJ TK RM DAB AS SNB. Contributed reagents/materials/analysis tools: CPM. Wrote the paper: VWT DAB AS SNB.","The authors have read the journal’s policy and have the following conflicts: DAB and SNB are named inventors on patents owned by St Vincent’s Hospital that pertain to the clinical use of MIC-1/GDF15 diagnostic assay and modulatory therapy. SBJ is an employee of Novo NorDisk, which has licensed MIC-1/GDF15 agonist therapeutic technology from St Vincent’s Hospital. There are no further patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2013","02","Vicky Wang-Wei Tsai","VWWT",17,TRUE,10,11,8,4,TRUE,TRUE,FALSE,0,NA,FALSE
